Allied Market Research
Loading...
0
New
New
2021
Plasma Therapy Market

Plasma Therapy Market by Type (Pure Platelet-Rich Plasma, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin, and Leukocyte-Rich Fibrin), Application (Orthopedics, Dermatology, Dentistry, and Others), and End User (Hospitals, Dermatology Clinics, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2030

A13680
Pages: 214
Sep 2021 | 156 Views
   
Author(s) : Smita Nerkar , Onkar Sumant
Tables: 148
Charts: 29
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • IComes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Plasma Therapy Market

Request Now !

Plasma Therapy Market Overview

The plasma therapy market size was valued at $350.21 million in 2020 and is projected to reach $698.46 million by 2030 registering a CAGR of 8.50% from 2021 to 2030. Blood plasma comprises platelets, autologous platelets, and cytokines, which help in healing of soft tissues. Plasma therapy is a traditional method broadly used in specialties of dentistry, dermatology, and orthopedics. Plasma therapy is extensively used in wound healing, androgenetic alopecia, and face rejuvenation. Plasma is concentrated up to 3–5 times of the physiological value and then injected into tissues where healing is required. In addition, convalescent plasma therapy may be given to people with COVID-19 who are in the hospital and are early in their illness, which further drive the plasma therapy market growth.

Growth of the global plasma therapy market is majorly driven by rise in prevalence of life-threatening diseases, which includes various neurological system disorders such as chronic inflammatory demyelinating polyneuropathy (CIPD), idiopathic thrombocytopenic purpura (ITP), and multifocal motor neuropathy (MMN). In addition, rise in occurrence of contagious diseases such as hepatitis A&B, tetanus, and rabies is estimated to impact the market positively during the forecast period. Furthermore, geriatric population suffers from various diseases and is more prone to infectious diseases, owing to weak immunity. This is expected to increase demand for plasma therapy, which is expected to boost the market growth. However, high cost of plasma therapy is anticipated to restrain the global plasma therapy market. In addition, rise in number of patients that are suffering from orthopedic disorders and androgenic alopecia further provide opportunities for the plasma therapy.

Plasma-Therapy-Market-2021-2030

Get more information on this report : Request Sample Pages

The outbreak of COVID-19 has disrupted workflows in the healthcare sector across the world. The disease has forced a number of industries to shut their doors temporarily, including several sub-domains of healthcare. Moreover, COVID-19 has positively impacted the plasma therapy market. On August 23, 2020, the FDA issued an emergency use authorization (EUA) for COVID-19 convalescent plasma for treatment of hospitalized patients with COVID-19 disease. Moreover, in March 2020, the Houston Methodist Hospital, U.S., announced that it was used plasma fractionation in the treatment of COVID-19. It became the first hospital in the U.S. to make use of plasma fractionation products in the fight against coronavirus disease pandemic.

Plasma from the blood of a patient who recovered from the COVID-19 was used for treatment of another patient suffering from COVID-19. Convalescent plasma can potentially develop as an effective treatment option to battle against the pandemic. Thus, rise in demand for plasma derived immunoglobulins for treatment procedures for COVID-19 patients with autoimmune and inflammatory disorders, which is anticipated to drive growth of the plasma fractionation market for immunoglobulin.

Plasma therapy market segmentation 

The global plasma therapy market is segmented into type, application, end user, and region. Depending on type, the market is bifurcated into pure platelet-rich plasma, leukocyte-rich PRP, pure platelet-rich fibrin, and leukocyte-rich fibrin. The application segment is further categorized into orthopedics, dermatology, dentistry, and others.

On the basis of end user, it is segregated into hospitals, dermatology clinics, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Segment Review

By type, the pure PRP segment is estimated to account for the largest share of the global plasma therapy market in 2020, owing to effective results of pure PRP therapy. Furthermore, rise in funding for health care and increase in use of PRP in hospitals and clinics propels the market. The pure platelet-rich segment is also set to have a healthy growth, owing to increased usage and antimicrobial effects.

Plasma Therapy Market
By Type

Your browser does not support the canvas element.

Pure Platelet Rich Plasma segment holds a dominant position in 2020 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

On the basis application, the orthopedic segment accounted for the largest share in 2020, owing to increase in occurrences of orthopedic disorders such as arthritis and rise in healthcare expenditure.

Plasma Therapy Market
By Application

Your browser does not support the canvas element.

Orthopedics segment is projected as one of the most lucrative segment.

Get more information on this report : Request Sample Pages

Snapshot of Asia-Pacific Plasma therapy market 

North America is projected to account for a major share of the global plasma therapy market during the forecast period. The market in the region is anticipated to grow in the future, owing to rise in research and developments made by government and private sectors. Asia-Pacific is also set to have a considerable growth, owing to increase in population and rise in awareness for blood donation. Increase in number of hospitals and clinics and presence of advanced plasma therapies propels the plasma therapy market growth.

Plasma Therapy Market
By Region

2030
North America 
Europe
Asia-pacific
Lamea

Asia-Pacific region would exhibit the highest CAGR of 10.8% during 2021-2030.

Get more information on this report : Request Sample Pages

Competitive Landscape

  • MTF Biologics
  • Regen Lab SA
  • Arthrex, Terumo Corporation
  • Zimmer Biomet.
  • Johnson & Johnson (DePuy Synthes)
  • Exactech, Inc.
  • Ony Biotech Inc.
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.

Key Benefits For Stakeholders

  • The study provides an in-depth analysis of the global plasma therapy market along with the current trends and future estimations to elucidate the imminent investment pockets.
  • A comprehensive analysis of the factors that drive and restrict the market growth is provided in the report.
  • Comprehensive quantitative analysis of the industry from 2020 to 2030 is provided to enable the stakeholders to capitalize on the prevailing plasma therapy market opportunities.
  • Extensive analysis of the key segments of the industry helps to understand the application and products the market used across the globe.
  • Key market players and their strategies have been analyzed to understand the competitive outlook of the plasma therapy market.

Key Market Segments

By Type

  • Pure Platelet-rich plasma (PRP)        
  • Leukocyte-Rich PRP    
  • Pure Platelet-Rich Fibrin       
  • Leukocyte-Rich Fibrin 

By Application

  • Orthopedics
  • Dermatology
  • Dentistry
  • Others

By End User

  • Hospitals
  • Dermatology Clinics
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
 

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key Benefits for Stakeholders
1.3.Key market segments

1.3.1.List of key players profiled in the report

1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET LANDSCAPE

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets

3.3.Porter’s five force analysis
3.4.Top player positioning, 2020
3.5.Market dynamics

3.5.1.Drivers

3.5.1.1.Surge in geriatric population across, coupled with rise in prevalence of rare diseases
3.5.1.2.Increase in number of plasma collection centers across the globe
3.5.1.3.Rise in the number of androgenic alopecia patients around the globe

3.5.2.Restraint

3.5.2.1.High cost of plasma derived products

3.5.3.Opportunity

3.5.3.1.High growth potential in emerging economies

3.5.4.Impact analysis

3.6.COVID-19 Impact analysis on the plasma therapy market

CHAPTER 4:PLASMA THERAPY MARKET, BY TYPE

4.1.Overview

4.1.1.Market size and forecast

4.2.Platelet-rich plasma (PRP)

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.2.1.Market size and forecast for pure platelet rich plasma by end users
4.2.3.Market analysis, by country

4.3.Leukocyte-Rich PRP

4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region

4.3.2.1.Market size and forecast for leukocyte rich prp by end users

4.3.3.Market analysis, by country

4.4.Pure Platelet-Rich Fibrin

4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by region
4.4.2.1.Market size and forecast for leukocyte rich prp by end users
4.4.3.Market analysis, by country

4.5.Leukocyte-Rich Fibrin

4.5.1.Key market trends, growth factors, and opportunities
4.5.2.Market size and forecast, by region
4.5.2.1.Market size and forecast for leukocyte rich fibrin by end users
4.5.3.Market analysis, by country

CHAPTER 5:PLASMA THERAPY MARKET, BY APPLICATION

5.1.Overview

5.1.1.Market size and forecast

5.2.Orthopedic

5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country

5.3.Dermatology

5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country

5.4.Dentistry

5.4.1.Market size and forecast, by region
5.4.2.Market analysis, by country

5.5.Others

5.5.1.Market size and forecast, by region
5.5.2.Market analysis, by country

CHAPTER 6:PLASMA THERAPY MARKET, BY END USER

6.1.Overview

6.1.1.Market size and forecast

6.2.Hospitals

6.2.1.Market size and forecast, by region
6.2.2.Market analysis, by country

6.3.Dermatology Clinics

6.3.1.Market size and forecast, by region
6.3.2.Market analysis, by country

6.4.Others

6.4.1.Market size and forecast, by region
6.4.2.Market analysis, by country

CHAPTER 7:PLASMA THERAPY MARKET, BY REGION

7.1.Overview

7.1.1.Market size and forecast

7.2.North America

7.2.1.Key market trends, growth factors, and opportunities
7.2.2.Market size and forecast, by country

7.2.2.1.U.S. plasma therapy market, by type
7.2.2.2.U.S. plasma therapy market, by type
7.2.2.3.U.S. plasma therapy market, by application
7.2.2.4.U.S. plasma therapy market, end user
7.2.2.5.Canada plasma therapy market
7.2.2.6.Canada plasma therapy market, by type
7.2.2.7.Canada plasma therapy market, by application
7.2.2.8.Canada plasma therapy market, end user
7.2.2.9.Mexico plasma therapy market
7.2.2.10.Mexico plasma therapy market, by type
7.2.2.11.Mexico plasma therapy market, by application
7.2.2.12.Mexico plasma therapy market, end user

7.2.3.North America market size and forecast, by type
7.2.4.North America market size and forecast, by application
7.2.5.North America market size and forecast, end user

7.3.Europe

7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Market size and forecast, by country

7.3.2.1.Germany plasma therapy market
7.3.2.2.Germany plasma therapy market, by type
7.3.2.3.Germany plasma therapy market, by application
7.3.2.4.Germany plasma therapy market, end user
7.3.2.5.France plasma therapy market
7.3.2.6.France plasma therapy market, by type
7.3.2.7.France plasma therapy market, by application
7.3.2.8.France plasma therapy market, end user
7.3.2.9.UK plasma therapy market
7.3.2.10.UK plasma therapy market, by type
7.3.2.11.UK plasma therapy market, by application
7.3.2.12.UK plasma therapy market, end user

7.3.2.13.Italy plasma therapy market
7.3.2.14.Italy plasma therapy market, by type
7.3.2.15.Italy plasma therapy market, by application
7.3.2.16.Italy plasma therapy market, end user
7.3.2.17.Spain plasma therapy market
7.3.2.18.Spain plasma therapy market, by type
7.3.2.19.Spain plasma therapy market, by application
7.3.2.20.Spain plasma therapy market, end user
7.3.2.21.Rest of Europe plasma therapy market
7.3.2.22.Rest of Europe plasma therapy market, by type
7.3.2.23.Rest of Europe Plasma therapy market, by application
7.3.2.24.Rest of Europe Plasma therapy market, end user

7.3.3.Europe market size and forecast, by type
7.3.4.Europe market size and forecast, application
7.3.5.Europe market size and forecast, end user

7.4.Asia-Pacific

7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Market size and forecast, by country

7.4.2.1.Japan Plasma therapy market
7.4.2.2.Japan Plasma therapy market, by type
7.4.2.3.Japan Plasma therapy market, by application
7.4.2.4.Japan Plasma therapy market, end user
7.4.2.5.China Plasma therapy market
7.4.2.6.China Plasma therapy market, by type
7.4.2.7.China plasma therapy market, by application
7.4.2.8.China plasma therapy market, end user
7.4.2.9.Australia plasma therapy market
7.4.2.10.Australia plasma therapy market, by type
7.4.2.11.Australia plasma therapy market, by application
7.4.2.12.Australia plasma therapy market, end user
7.4.2.13.India plasma therapy market, by type
7.4.2.14.India plasma therapy market, by type
7.4.2.15.India plasma therapy market, by application
7.4.2.16.India plasma therapy market, end user
7.4.2.17.South Korea plasma therapy market
7.4.2.18.South Korea plasma therapy market, by type
7.4.2.19.South Korea plasma therapy market, by application
7.4.2.20.South Korea plasma therapy market, end user
7.4.2.21.Rest of Asia-Pacific plasma therapy market
7.4.2.22.Rest of Asia-Pacific plasma therapy market
7.4.2.23.Rest of Asia-Pacific plasma therapy market, by application
7.4.2.24.Rest of Asia-Pacific plasma therapy market, end user

7.4.3.Asia-Pacific market size and forecast, by type
7.4.4.Asia-Pacific market size and forecast, by application
7.4.5.Asia-Pacific market size and forecast, end user

7.5.LAMEA

7.5.1.Key market trends, growth factors, and opportunities
7.5.2.Market size and forecast, by country

7.5.2.1.Brazil plasma therapy market
7.5.2.2.Brazil plasma therapy market, by type
7.5.2.3.Brazil plasma therapy market, by application
7.5.2.4.Brazil plasma therapy market, end user
7.5.2.5.Saudi Arabia plasma therapy market
7.5.2.6.Saudi Arabia plasma therapy market, by type
7.5.2.7.Saudi Arabia plasma therapy market, by application
7.5.2.8.Saudi Arabia plasma therapy market, end user
7.5.2.9.South Africa plasma therapy market
7.5.2.10.South Africa plasma therapy market, by type
7.5.2.11.South Africa plasma therapy market, by application
7.5.2.12.South Africa plasma therapy market, end user
7.5.2.13.Rest of LAMEA plasma therapy market
7.5.2.14.Rest of LAMEA plasma therapy market, by type
7.5.2.15.Rest of LAMEA plasma therapy market, by application
7.5.2.16.Rest of LAMEA plasma therapy market, end user

7.5.3.LAMEA market size and forecast, by type
7.5.4.LAMEA market size and forecast, by application
7.5.5.LAMEA market size and forecast, end user

CHAPTER 8:COMPANY PROFILES

8.1.Arthrex Inc.

8.1.1.Company overview
8.1.2.Operating business segments
8.1.3.Product portfolio

8.2.BTI Biotechnology Institute

8.2.1.Company overview
8.2.2.Operating business segments
8.2.3.Product portfolio

8.3.Exactech AG

8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio

8.4.Genesis Biologics Inc.

8.4.1.Company overview
8.4.2.Operating business segments
8.4.3.Product portfolio

8.5.Isto Biologics

8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio

8.6.JOHNSON & JOHNSON (DEPUY SYNTHES)

8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product Portfolio
8.6.5.Business performance

8.7.MUSCULOSKELETAL TRANSPLANT FOUNDATION

8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product Portfolio

8.8.Regen Lab SA

8.8.1.Company overview
8.8.2.Operating business segments
8.8.3.Product portfolio

8.9.TERUMO CORPORATION (Terumo BCT)

8.9.1.Company overview
8.9.2.Operating business segments
8.9.3.Product portfolio
8.9.4.Business performance
8.9.5.Key strategic moves and developments

8.10.ZIMMER BIOMET HOLDINGS, INC.,

8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio
8.10.5.Business performance

LIST OF TABLES

TABLE 01.PLASMA THERAPY MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 02.PLATELET-RICH PLASMA (PRP) MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 03.INDIRECT VENT MARKET, BY END USER, 2020-2030($MILLION)
TABLE 04.LEUKOCYTE-RICH PRP MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 05.LEUKOCYTE RICH PRP MARKET, BY END USER, 2020-2030($MILLION)
TABLE 06.PURE PLATELET-RICH FIBRIN MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 07.PURE PLATELET RICH MARKET, BY END USER, 2020-2030($MILLION)
TABLE 08.LEUKOCYTE-RICH FIBRIN MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 09.LEUKOCYTE RICH FIBRIN MARKET, BY END USER, 2020-2030($MILLION)
TABLE 10.PLASMA THERAPY MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 11.ORTHOPEDIC MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 12.DERMATOLOGY MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 13.DENTISTRY MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 14.OTHERS MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 15.PLASMA THERAPY MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 16.HOSPITALS MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 17.DERMATOLOGY CLINICS MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 18.OTHERS MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 19.PLASMA THERAPY MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 20.NORTH AMERICA PLASMA THERAPY MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 21.U.S. PLASMA THERAPY MARKET, BY TYPE, 2020-2030
TABLE 22.U.S. PLASMA THERAPY MARKET, BY APPLICATION, 2020-2030
TABLE 23.U.S. PLASMA THERAPY MARKET, END USER, 2020-2030
TABLE 24.CANADA PLASMA THERAPY MARKET, BY TYPE, 2020-2030
TABLE 25.CANADA PLASMA THERAPY MARKET, BY APPLICATION, 2020-2030
TABLE 26.CANADA PLASMA THERAPY MARKET, END USER, 2020-2030
TABLE 27.MEXICO PLASMA THERAPY MARKET, BY TYPE, 2020-2030
TABLE 28.MEXICO PLASMA THERAPY MARKET, BY APPLICATION, 2020-2030
TABLE 29.MEXICO PLASMA THERAPY MARKET, END USER, 2020-2030
TABLE 30.NORTH AMERICA PLASMA THERAPY MARKET, BY TYPE, 2020-2030
TABLE 31.NORTH AMERICA PLASMA THERAPY MARKET, BY APPLICATION, 2020-2030
TABLE 32.NORTH AMERICA PLASMA THERAPY MARKET, END USER, 2020-2030
TABLE 33.EUROPE PLASMA THERAPY MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 34.GERMANY PLASMA THERAPY MARKET, BY TYPE, 2020-2030
TABLE 35.GERMANY PLASMA THERAPY MARKET, BY APPLICATION, 2020-2030
TABLE 36.GERMANY PLASMA THERAPY MARKET, END USER, 2020-2030
TABLE 37.FRANCE PLASMA THERAPY MARKET, BY TYPE, 2020-2030
TABLE 38.FRANCE PLASMA THERAPY MARKET, BY APPLICATION, 2020-2030
TABLE 39.FRANCE PLASMA THERAPY MARKET, END USER, 2020-2030
TABLE 40.UK PLASMA THERAPY MARKET, BY TYPE, 2020-2030
TABLE 41.UK PLASMA THERAPY MARKET, BY APPLICATION, 2020-2030
TABLE 42.UK PLASMA THERAPY MARKET, END USER, 2020-2030
TABLE 43.ITALY PLASMA THERAPY MARKET, BY TYPE, 2020-2030
TABLE 44.ITALY PLASMA THERAPY MARKET, BY APPLICATION, 2020-2030
TABLE 45.ITALY PLASMA THERAPY MARKET, END USER, 2020-2030
TABLE 46.SPAIN PLASMA THERAPY MARKET, BY TYPE, 2020-2030
TABLE 47.SPAIN PLASMA THERAPY MARKET, BY APPLICATION, 2020-2030
TABLE 48.SPAIN PLASMA THERAPY MARKET, END USER, 2020-2030
TABLE 49.REST OF EUROPE PLASMA THERAPY MARKET, BY TYPE, 2020-2030
TABLE 50.REST OF EUROPE PLASMA THERAPY MARKET, BY APPLICATION, 2020-2030
TABLE 51.REST OF EUROPE PLASMA THERAPY MARKET, END USER, 2020-2030
TABLE 52.EUROPE PLASMA THERAPY MARKET, BY TYPE, 2020-2030
TABLE 53.EUROPE PLASMA THERAPY MARKET, APPLICATION, 2020-2030
TABLE 54.EUROPE PLASMA THERAPY MARKET, END USER, 2020-2030
TABLE 55.ASIA-PACIFIC PLASMA THERAPY MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 56.JAPAN PLASMA THERAPY MARKET, BY TYPE, 2020-2030
TABLE 57.JAPAN PLASMA THERAPY MARKET, BY APPLICATION, 2020-2030
TABLE 58.JAPAN PLASMA THERAPY MARKET, END USER, 2020-2030
TABLE 59.CHINA PLASMA THERAPY MARKET, BY TYPE, 2020-2030
TABLE 60.CHINA PLASMA THERAPY MARKET, BY APPLICATION, 2020-2030
TABLE 61.CHINA PLASMA THERAPY MARKET, END USER, 2020-2030
TABLE 62.AUSTRALIA PLASMA THERAPY MARKET, BY TYPE, 2020-2030
TABLE 63.AUSTRALIA PLASMA THERAPY MARKET, BY APPLICATION, 2020-2030
TABLE 64.AUSTRALIA PLASMA THERAPY MARKET, END USER, 2020-2030
TABLE 65.INDIA PLASMA THERAPY MARKET, BY TYPE, 2020-2030
TABLE 66.INDIA PLASMA THERAPY MARKET, BY APPLICATION, 2020-2030
TABLE 67.INDIA PLASMA THERAPY MARKET, BY END USER, 2020-2030
TABLE 68.SOUTH KOREA PLASMA THERAPY MARKET, BY TYPE, 2020-2030
TABLE 69.SOUTH KOREAPLASMA THERAPY MARKET, BY APPLICATION, 2020-2030
TABLE 70.SOUTH KOREA PLASMA THERAPY MARKET, END USER, 2020-2030
TABLE 71.REST OF ASIA-PACIFIC PLASMA THERAPY MARKET, BY TYPE, 2020-2030
TABLE 72.REST OF ASIA-PACIFIC PLASMA THERAPY MARKET, BY APPLICATION, 2020-2030
TABLE 73.REST OF ASIA-PACIFIC PLASMA THERAPY MARKET, END USER, 2020-2030
TABLE 74.ASIA-PACIFIC PLASMA THERAPY MARKET, BY TYPE, 2020-2030
TABLE 75.ASIA-PACIFIC PLASMA THERAPY MARKET, BY APPLICATION, 2020-2030
TABLE 76.ASIA-PACIFIC PLASMA THERAPY MARKET, END USER, 2020-2030
TABLE 77.LAMEA PLASMA THERAPY MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 78.BRAZIL PLASMA THERAPY MARKET, BY TYPE, 2020-2030
TABLE 79.BRAZIL PLASMA THERAPY MARKET, BY APPLICATION, 2020-2030
TABLE 80.BRAZIL PLASMA THERAPY MARKET, END USER, 2020-2030
TABLE 81.SAUDI ARABIA PLASMA THERAPY MARKET, BY TYPE, 2020-2030
TABLE 82.SAUDI ARABIA PLASMA THERAPY MARKET, BY APPLICATION, 2020-2030
TABLE 83.SAUDI ARABIA PLASMA THERAPY MARKET, END USER, 2020-2030
TABLE 84.SOUTH AFRICA PLASMA THERAPY MARKET, BY TYPE, 2020-2030
TABLE 85.SOUTH AFRICA PLASMA THERAPY MARKET, BY APPLICATION, 2020-2030
TABLE 86.SOUTH AFRICA PLASMA THERAPY MARKET, END USER, 2020-2030
TABLE 87.REST OF LAMEA PLASMA THERAPY MARKET, BY TYPE, 2020-2030
TABLE 88.REST OF LAMEA PLASMA THERAPY MARKET, BY APPLICATION, 2020-2030
TABLE 89.REST OF LAMEA PLASMA THERAPY MARKET, END USER, 2020-2030
TABLE 90.LAMEA PLASMA THERAPY MARKET, BY TYPE, 2020-2030
TABLE 91.LAMEA PLASMA THERAPY MARKET, BY APPLICATION, 2020-2030
TABLE 92.LAMEA PLASMA THERAPY MARKET, END USER, 2020-2030
TABLE 93.ARTHREX: COMPANY SNAPSHOT
TABLE 94.ARTHREX: OPERATING SEGMENTS
TABLE 95.ARTHREX: PRODUCT PORTFOLIO
TABLE 96.BTI: COMPANY SNAPSHOT
TABLE 97.BTI: OPERATING SEGMENTS
TABLE 98.BTI: PRODUCT PORTFOLIO
TABLE 99.EXACTECH: SNAPSHOT
TABLE 100.EXACTECH: OPERATING SEGMENTS
TABLE 101.EXACTECH: PRODUCT PORTFOLIO
TABLE 102.GENESIS BIOLOGICS: COMPANY SNAPSHOT
TABLE 103.GENESIS BIOLOGICS: OPERATING SEGMENTS
TABLE 104.GENESIS BIOLOGICS: PRODUCT PORTFOLIO
TABLE 105.ISTO BIOLOGICS: SNAPSHOT
TABLE 106.ISTO BIOLOGICS: OPERATING SEGMENTS
TABLE 107.ISTO BIOLOGICS: PRODUCT PORTFOLIO
TABLE 108.J&J: COMPANY SNAPSHOT
TABLE 109.J&J: Operating SEGMENTS
TABLE 110.J&J: PRODUCT PORTFOLIO
TABLE 111.MTF BIOLOGICS: COMPANY SNAPSHOT
TABLE 112.MTF BIOLOGICS: PRODUCT OFFERINGS
TABLE 113.MTF BIOLOGICS: PRODUCT PORTFOLIO
TABLE 114.REGENLAB: COMPANY SNAPSHOT
TABLE 115.REGENLAB: OPERATING SEGMENTS:
TABLE 116.REGENLAB: PRODUCT PORTFOLIO
TABLE 117.TERUMO: COMPANY SNAPSHOT
TABLE 118.TERUMO: OPERATING SEGMENTS
TABLE 119.TERUMO: PRODUCT PORTFOLIO
TABLE 120.ZIMMER BIOMET: COMPANY SNAPSHOT
TABLE 121.ZIMMER BIOMET: OPERATING SEGMENTS
TABLE 122.ZIMMER BIOMET: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01.PLASMA THERAPY MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 04.MODERATE BARGAINING POWER OF BUYERS
FIGURE 05.MODERATE THREAT OF SUBSTITUTES
FIGURE 06.HIGH THREAT OF NEW ENTRANTS
FIGURE 07.MODERATE INTENSITY OF RIVALRY
FIGURE 08.TOP PLAYER POSITIONING, 2020
FIGURE 09.IMPACT ANALYSIS
FIGURE 10.COMPARATIVE ANALYSIS OF PLATELET-RICH PLASMA (PRP) MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 11.COMPARATIVE ANALYSIS OF LEUKOCYTE-RICH PRP MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 12.COMPARATIVE ANALYSIS OF PURE PLATELET-RICH FIBRIN MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 13.COMPARATIVE ANALYSIS OF LEUKOCYTE-RICH FIBRIN MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 14.COMPARATIVE ANALYSIS OF ORTHOPEDIC MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 15.COMPARATIVE ANALYSIS OF DERMATOLOGY MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 16.COMPARATIVE ANALYSIS OF DENTISTRY MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 17.COMPARATIVE ANALYSIS OF OTHERS MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 18.COMPARATIVE ANALYSIS OF HOSPITALS MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 19.COMPARATIVE ANALYSIS OF DERMATOLOGY CLINICS MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 20.COMPARATIVE ANALYSIS OF OTHERS MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 21.J&J: REVENUE, 2018–2020 ($MILLION)
FIGURE 22.J&J: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 23.J&J: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 24.TERUMO: NET SALES, 2018–2020 ($MILLION)
FIGURE 25.TERUMO: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 26.TERUMO: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 27.ZIMMER BIOMET: NET SALES, 2018–2020 ($MILLION)
FIGURE 28.ZIMMER BIOMET: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 29.ZIMMER BIOMET: REVENUE SHARE BY REGION, 2020 (%)

 
 

The plasma therapy market growth includes increase in technological advancements and utilization of plasma therapy in various life-threatening diseases, which is anticipated to boost growth of the global plasma therapy market in the next few years. Moreover, rise in demand for plasma therapy in surgery of orthopedic and other treatments propels the market growth. Increase in developments of plasma therapies for different types of diseases and increase in blood donations propel the market growth.

Furthermore, the plasma therapy market is dominated by North America, owing to increase in research and developments made by government and private sectors. Asia-Pacific is also set to have a considerable growth, owing to increase in population and rise in awareness for blood donation. Increase in number of hospitals and clinics and presence of advanced plasma therapies propels the market growth.

PURCHASE OPTIONS

Start reading instantly ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Call or Email us

U.S.-Canada
Toll-free :
+1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com
FREQUENTLY ASKED QUESTIONS?
Our Report Looks Like This
 

A. The total market value of Plasma Therapy market is $350.21 million in 2020.

A. The forcast period for Plasma Therapy market is 2021 to 2030

A. The market value of Plasma Therapy market in 2021 is $334.24 million.

A. The base year is 2020 in Plasma Therapy market

A. Top companies such as Arthrex, BTI Biotechnology Institute, Exactech, Inc, Genesis Biologics, Isto Biologics, Johnson & Johnson (DePuy Synthes), MTF Biologics, Regen Lab SA, Terumo Corporation, Zimmer Biomet held a high market position in 2020.

A. By type, the pure PRP segment is estimated to account for the largest share of the global market in 2020, owing to effective results of pure PRP therapy. Furthermore, rise in funding for health care and increase in use of PRP in hospitals and clinics propels the market. The pure platelet-rich segment is also set to have a healthy growth, owing to increased usage and antimicrobial effects.

A. Growth of the global plasma therapy market is majorly driven by rise in prevalence of life-threatening diseases, which includes various neurological system disorders such as chronic inflammatory demyelinating polyneuropathy (CIPD), idiopathic thrombocytopenic purpura (ITP), and multifocal motor neuropathy (MMN). In addition, rise in occurrence of contagious diseases such as hepatitis A&B, tetanus, and rabies is estimated to impact the market positively during the forecast period.

A. North America is projected to account for a major share of the global plasma therapy market during the forecast period. The market in the region is anticipated to grow in the future, owing to rise in research and developments made by government and private sectors. Asia-Pacific is also set to have a considerable growth, owing to increase in population and rise in awareness for blood donation. Increase in number of hospitals and clinics and presence of advanced plasma therapies propels the market growth.

Allied Market Research Allied Market Research Allied Market Research
RELATED TAGS
 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Sample

OR

Purchase Full Report of
Plasma Therapy Market

Start reading instantly.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,712
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $4,125
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $6,168
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,929
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $10,663
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Erythropoietin Drugs Market

Global Opportunity Analysis and Industry Forecast, 2021–2028

Published in May 2021

Download Sample

Protein Therapeutics Market

Global Opportunity Analysis and Industry Forecast, 2017-2023

Published in Nov 2017

Download Sample

Surgical Equipment Market

Global Opportunity Analysis and Industry Forecast, 2020-2027

Published in Jan 2021

Download Sample

Medical Implant Market

Global Opportunity Analysis and Industry Forecast, 2020–2027

Published in Nov 2020

Download Sample

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers